We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current VTRS market cap is 14.06B. The company's latest EPS is USD 0.0461 and P/E is 256.62.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 4.08B | 3.88B | 3.73B | 3.93B | 3.97B |
| Operating Income | 560.1M | -201.3M | 399.8M | 368.6M | 451.7M |
| Net Income | 354.3M | 1.01B | 224.7M | 264M | 331.6M |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 11.95B | 17.89B | 16.26B | 15.43B |
| Operating Income | -259.2M | -95.9M | 1.61B | 766.2M |
| Net Income | -669.9M | -1.27B | 2.08B | 54.7M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 48.66B | 50.02B | 49.29B | 48.7B | 48.74B |
| Total Liabilities | 29.48B | 28.95B | 28.36B | 27.85B | 27.88B |
| Total Equity | 19.18B | 21.07B | 20.93B | 20.84B | 20.87B |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 61.55B | 54.84B | 50.02B | 47.69B |
| Total Liabilities | 38.6B | 34.35B | 28.95B | 27.22B |
| Total Equity | 22.95B | 20.49B | 21.07B | 20.47B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | 2.81B | 2.95B | 971.2M | 1.49B | 2.32B |
| Investing | -264M | 1.52B | -749.5M | -826.1M | -879.9M |
| Financing | -2.55B | -3.88B | -974.7M | -1.28B | -1.38B |
| Year End December 30 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 1.23B | 3.02B | 2.95B | 2.8B |
| Investing | -301.1M | -117.8M | 1.52B | -764.1M |
| Financing | -605.7M | -3.01B | -3.88B | -2.3B |
| Market Cap | 14.06B |
| Price to Earnings Ratio | 256.62 |
| Price to Sales Ratio | 0.91 |
| Price to Cash Ratio | 14.16 |
| Price to Book Ratio | 0.69 |
| Dividend Yield | 4.05% |
| Shares Outstanding | 1.19B |
| Average Volume (1 week) | 9.58M |
| Average Volume (1 Month) | 6.8M |
| 52 Week Change | 23.33% |
| 52 Week High | 13.6175 |
| 52 Week Low | 8.74 |
| Spread (Intraday) | 0.15 (1.27%) |
| Company Name | Viatris Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.viatris.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
